DIALYSIS

This study tested the long-term safety of a drug called MCI-196 in 116 adults with advanced chronic kidney disease who are on dialysis and have high phosphorus levels. The goal was to see if the drug is safe and helps control phosphorus over a year. Participants took flexible dos…

This study tested a drug called MCI-196 in 245 adults on dialysis with high phosphate levels. After a 12-week dose adjustment period, some patients switched to a placebo for 4 weeks to see if the drug truly kept phosphate levels down. The goal was to manage a common complication …

This study tested an automated insulin delivery system (a smart pump) in 15 adults with type 1 or type 2 diabetes who also had advanced kidney disease or were on dialysis. Participants used the system for 8 weeks, then switched to their usual care for another 8 weeks. The goal wa…

This study tested a new drug called AP301 in 474 adults with kidney failure who are on dialysis and have high phosphorus levels. High phosphorus can cause bone and heart problems. The goal was to see if AP301 lowers phosphorus better than the current standard treatment, sevelamer…

This study tested the long-term safety of a drug called MCI-196 in 632 adults with advanced kidney disease on dialysis who have high phosphorus levels. Participants took the drug for up to 52 weeks to see how well it controls phosphorus and lowers LDL cholesterol. The goal is to …

This study tested a drug called MCI-196 in 642 adults on dialysis who had high phosphorus and cholesterol levels. Participants took either MCI-196 or a placebo for 12 weeks to see if the drug could safely lower both phosphorus and LDL cholesterol. The goal is to help manage heart…

This study examined how often patients in Reunion Island start dialysis as an emergency and what factors contribute to this. Researchers collected data from 233 adults beginning dialysis in local centers. The goal was to identify social and medical reasons behind emergency starts…

This study looked at 60 adults on long-term dialysis to see if the schedule of dialysis sessions affects blood flow to the legs. Some patients had standard 4-hour sessions three times a week, while others had 2-hour sessions six times a week. The goal was to find out which schedu…

This study looked at 167 adults with kidney failure who were on either hemodialysis or peritoneal dialysis. Researchers compared their blood levels of calcium, phosphorus, and other minerals to see how each dialysis type affects bone health. The goal was to gather information, no…

This study tested a communication tool called "Best Case/Worst Case" to help older adults with end-stage kidney disease and their doctors talk about treatment options, including palliative care. Over 400 patients from ten kidney clinics took part, with some doctors trained to use…